Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'METASTATIC MELANOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1068 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kemminer, SE; Conradt, HS; Nimtz, M; Sagi, D; Peter-Katalinic, J; Diekmann, O; Drmic, I; Muthing, J
      Production and molecular characterization of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24

      BIOTECHNOLOGY PROGRESS
    2. Elliott, D; Pitman, MB
      Malignant melanoma with a myxoid stroma: A diagnostic pitfall on fine-needle aspiration biopsy

      DIAGNOSTIC CYTOPATHOLOGY
    3. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients

      INTERNATIONAL IMMUNOPHARMACOLOGY
    4. Pappo, I; Lotem, M; Klein, M; Orda, R
      Bolus high dose interleukin-2 for the treatment of malignant melanoma

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    5. Wang, E; Marincola, FM
      cDNA arrays and the enigma of melanoma immune responsiveness

      CANCER JOURNAL
    6. Sondak, VK
      Adjuvant therapy for melanoma

      CANCER JOURNAL
    7. Singh, S; Cunningham, C; Buchanan, A; Jolly, DJ; Nemunaitis, J
      Toxicity assessment of intratumoral injection of the herpes simplex type Ithymidine kinase gene delivered by retrovirus in patients with refractory cancer

      MOLECULAR THERAPY
    8. Nguyen, CL; Bui, JT; Demcheva, M; Vournakis, JN; Cole, DJ; Gillanders, WE
      Sustained release of granulocyte-macrophage colony-stimulating factor froma modular peptide-based cancer vaccine alters vaccine microenvironment andenhances the antigen-specific T-cell response

      JOURNAL OF IMMUNOTHERAPY
    9. Schwartzentruber, DJ
      Guidelines for the safe administration of high-dose interleukin-2

      JOURNAL OF IMMUNOTHERAPY
    10. Zeng, G
      MHC class II-restricted tumor antigens recognized by CD4(+) T cells: New strategies for cancer vaccine design

      JOURNAL OF IMMUNOTHERAPY
    11. Riley, JP; Rosenberg, SA; Parkhurst, MR
      Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase

      JOURNAL OF IMMUNOTHERAPY
    12. Xu, YX; Gao, XH; Janakiraman, N; Chapman, RA; Gautam, SC
      IL-12 gene therapy of leukemia with hematopoietic progenitor cells withoutthe toxicity of systemic IL-12 treatment

      CLINICAL IMMUNOLOGY
    13. Dobrzanski, MJ; Reome, JB; Dutton, RW
      Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection

      CLINICAL IMMUNOLOGY
    14. Wang, RF
      The role of MHC class II-restricted tumor antigens and CD4(+) T cells in antitumor immunity

      TRENDS IN IMMUNOLOGY
    15. Overwijk, WW; Restifo, NP
      Creating therapeutic cancer vaccines: notes from the battlefield

      TRENDS IN IMMUNOLOGY
    16. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    17. Wang, E; Phan, GQ; Marincola, FM
      T-cell-directed cancer vaccines: the melanoma model

      EXPERT OPINION ON BIOLOGICAL THERAPY
    18. Beck, A; Bussat, MC; Klinguer-Hamour, C; Goetsch, L; Aubry, JP; Champion, T; Julien, E; Haeuw, JF; Bonnefoy, JY; Corvaia, N
      Stability and CTL activity of N-terminal glutamic acid containing peptides

      JOURNAL OF PEPTIDE RESEARCH
    19. Hartleb, J; Arndt, R
      Cysteine and indole derivatives as markers for malignant melanoma

      JOURNAL OF CHROMATOGRAPHY B
    20. Mohammed, MQ; Abraha, HD; Sherwood, RA; MacRae, K; Retsas, S
      Serum S100 beta protein as a marker of disease activity in patients with malignant melanoma

      MEDICAL ONCOLOGY
    21. Schmuth, M; Spotl, L; Zelger, BG; Weinlich, G; Zelger, B
      Clear cells in acral melanoma

      EUROPEAN JOURNAL OF DERMATOLOGY
    22. Fagnoni, FF; Della Cuna, GR
      Immunotherapy: On the edge between experimental and clinical oncology

      JOURNAL OF CHEMOTHERAPY
    23. Buzaid, AC; Atkins, M
      Practical guidelines for the management of biochemotherapy-related toxicity in melanoma

      CLINICAL CANCER RESEARCH
    24. Sadanaga, N; Nagashima, H; Mashino, K; Tahara, K; Yamaguchi, H; Ohta, M; Fujie, T; Tanaka, F; Inoue, H; Takesako, K; Akiyoshi, T; Mori, M
      Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas

      CLINICAL CANCER RESEARCH
    25. Skog, ALH; Wadhwa, M; Hassan, M; Gharizadeh, B; Bird, C; Ragnhammar, P; Thorpe, R; Mellstedt, H
      Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2

      CLINICAL CANCER RESEARCH
    26. Rakhmilevich, AL; Imboden, M; Hao, ZL; Macklin, MD; Roberts, T; Wright, KM; Albertini, MR; Yang, NS; Sondel, PM
      Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding gp100 and granulocyte-macrophage colony-stimulating factor

      CLINICAL CANCER RESEARCH
    27. Gajewski, TF; Fallarino, F; Ashikari, A; Sherman, M
      Immunization of HLA-A2(+) melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant humaninterleukin 12

      CLINICAL CANCER RESEARCH
    28. Dworacki, G; Meidenbauer, N; Kuss, I; Hoffmann, TK; Gooding, W; Lotze, M; Whiteside, TL
      Decreased zeta chain expression and apoptosis in CD3(+) peripheral blood Tlymphocytes of patients with melanoma

      CLINICAL CANCER RESEARCH
    29. Mailliard, RB; Lotze, MT
      Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targets

      CLINICAL CANCER RESEARCH
    30. Wood, TF; DiFronzo, LA; Rose, DM; Haigh, PL; Stern, SL; Wanek, L; Essner, R; Morton, DL
      Does complete, resection of melanoma metastatic to solid intra-abdominal organs improve survival?

      ANNALS OF SURGICAL ONCOLOGY
    31. Habal, N; Gupta, RK; Bilchik, AJ; Yee, R; Leopoldo, Z; Ye, W; Elashoff, RM; Morton, DL
      CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer

      ANNALS OF SURGICAL ONCOLOGY
    32. Porter, GA; Abdalla, J; Lu, MS; Smith, S; Montgomery, D; Grimm, E; Ross, MI; Mansfield, PF; Gershenwald, JE; Lee, JE
      Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes

      ANNALS OF SURGICAL ONCOLOGY
    33. Witzke, O; Winterhagen, T; Saller, B; Roggenbuck, U; Lehr, I; Philipp, T; Mann, K; Reinhardt, W
      Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2

      THYROID
    34. O'Brien, CJ; McNeil, EB; McMahon, JD; Pathak, I; Lauer, CS
      Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    35. Pathak, I; O'Brien, CJ; Petersen-Schaeffer, K; McNeil, EB; McMahon, J; Quinn, MJ; Thompson, JF; McCarthy, WH
      Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    36. Airoldi, M; De Stefani, A; Marchionatti, S; Pedani, F; Gabriele, P; Ragona, R; Cortesina, G; Bumma, C
      Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    37. Kaufman, HL; DeRaffele, G; Divito, J; Horig, H; Lee, D; Panicali, D; Voulo, M
      A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma

      HUMAN GENE THERAPY
    38. Weber, JS; Aparicio, A
      Novel immunologic approaches to the management of malignant melanoma

      CURRENT OPINION IN ONCOLOGY
    39. Fiedler, W; Kruger, W; Laack, E; Mende, T; Vohwinkel, G; Hossfeld, DK
      A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients withadvanced colorectal cancer

      ONCOLOGY REPORTS
    40. Hasselmann, DO; Rappl, G; Rossler, M; Ugurel, S; Tilgen, W; Reinhold, U
      Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma

      ONCOLOGY REPORTS
    41. Schirrmacher, V; Griesbach, A; Ahlert, T
      Antitumor effects of Newcastle disease virus in vivo: local versus systemic effects

      INTERNATIONAL JOURNAL OF ONCOLOGY
    42. Dummer, R; Bosch, U; Panizzon, R; Bloch, PH; Burg, G
      Swiss guidelines for the treatment and follow-up of cutaneous melanoma

      DERMATOLOGY
    43. Juergensen, A; Holzapfel, U; Hein, R; Stolz, W; Buettner, R; Bosserhoff, AK
      Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta

      TUMOR BIOLOGY
    44. Willemsen, RA; Debets, R; Hart, E; Hoogenboom, HR; Bolhuis, RLH; Chames, P
      A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

      GENE THERAPY
    45. Gilhooly, EM; Morse-Gaudio, M; Bianchi, L; Reinhart, L; Rose, DP; Connolly, JM; Reed, JA; Albino, AP
      Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

      MELANOMA RESEARCH
    46. Guven, K; Kittler, H; Wolff, K; Pehamberger, H
      Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients

      MELANOMA RESEARCH
    47. Hofbauer, GFL; Geertsen, R; Laine, E; Burg, G; Dummer, R
      Impact of interferons on the expression of melanoma-associated antigens inmelanoma short-term cell cultures

      MELANOMA RESEARCH
    48. Deichmann, M; Benner, A; Kuner, N; Wacker, J; Waldmann, V; Naher, H
      Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100 beta or melanoma inhibitory activity (MIA)?

      MELANOMA RESEARCH
    49. Nikkola, J; Vihinen, P; Vlaykova, T; Hahka-Kemppinen, M; Kahari, VM; Pyrhonen, S
      High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma

      MELANOMA RESEARCH
    50. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    51. Eggermont, AMM
      The role interferon-alpha in malignant melanoma remains to be defined

      EUROPEAN JOURNAL OF CANCER
    52. Vuoristo, MS; Laine, S; Huhtala, H; Parvinen, LM; Hahka-Kemppinen, M; Korpela, M; Kumpulainen, E; Kellokumpu-Lehtinen, P
      Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma

      EUROPEAN JOURNAL OF CANCER
    53. Kampinga, HH; Dikomey, E
      Hyperthermic radiosensitization: mode of action and clinical relevance

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    54. Rosenberg, SA
      Progress in the development of immunotherapy for the treatment of patientswith cancer

      JOURNAL OF INTERNAL MEDICINE
    55. Yee, C; Riddell, SR; Greenberg, PD
      In vivo tracking of tumor-specific T cells

      CURRENT OPINION IN IMMUNOLOGY
    56. Fima, E; Shtutman, M; Libros, P; Missel, A; Shahaf, G; Kahana, G; Livneh, E
      PKC eta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells

      ONCOGENE
    57. Ricci, R; Maggiano, N; Martini, M; Mule, AMA; Pierconti, F; Capelli, A; Larocca, LM
      Primary malignant melanoma of the gallbladder in dysplastic naevus syndrome

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    58. Leonetti, C; Biroccio, A; Benassi, B; Stringaro, A; Stoppacciaro, A; Semple, SC; Zupi, G
      Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line

      CANCER GENE THERAPY
    59. Moretti, S; Carli, P; Biggeri, A; Volpi, V; Pimpinelli, N
      Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    60. Saida, T
      Recent advances in melanoma research

      JOURNAL OF DERMATOLOGICAL SCIENCE
    61. Takenoyama, M; Yoshino, I; Eifuku, R; So, T; Imahayashi, S; Sugaya, M; Yasuda, M; Inoue, M; Ichiyoshi, Y; Osaki, T; Nagashima, A; Nomoto, K; Yasumoto, K
      Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    62. Caruso, RD; Postel, GC; McDonald, CS; Sherry, RG
      High signal on T1-weighted MR images of the head: A pictorial essay

      CLINICAL IMAGING
    63. Toda, M; Iizuka, Y; Yu, W; Imai, T; Ikeda, E; Yoshida, K; Kawase, T; Kawakami, Y; Okano, H; Uyemura, K
      Expression of the neural RNA-binding protein musashi1 in human gliomas

      GLIA
    64. Meyskens, FL; Farmer, P; Fruehauf, JP
      Redox regulation in human melanocytes and melanoma

      PIGMENT CELL RESEARCH
    65. Thomas, C; Yuki, N; Fertil, B
      Influence of gangliosides or LPS-like gangliosides on the tumoricidal activity of adherent leukocytes

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    66. Ricaniadis, N; Kataki, A; Agnantis, N; Androulakis, G; Karakousis, CP
      Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    67. Reintgen, D; Cruse, CW; Atkins, M
      Cutaneous malignant melanoma

      CLINICS IN DERMATOLOGY
    68. Nemunaitis, J; Fong, T; Shabe, P; Martineau, D; Ando, D
      Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma

      CANCER INVESTIGATION
    69. Nguyen, NP; Sallah, S; Childress, C; Salehpour, MR; Karlsson, U
      Interferon-alpha combined with radiotherapy in the treatment of unresectable melanoma

      CANCER INVESTIGATION
    70. Bonaccorsi, P; Ansel, JC; Armstrong, CA
      Management of high-risk melanoma

      DERMATOLOGIC CLINICS
    71. Kirkwood, JM; Ibrahim, JG; Sosman, JA; Sondak, VK; Agarwala, SS; Ernstoff, MS; Rao, U
      High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801

      JOURNAL OF CLINICAL ONCOLOGY
    72. Kelley, MC; Gupta, RK; Hsueh, EC; Yee, R; Stern, S; Morton, DL
      Tumor-associated antigen TA90 immune complex assay predicts recurrence andsurvival after surgical treatment of stage I-III melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    73. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
      Patient preferences for adjuvant interferon alfa-2b treatment

      JOURNAL OF CLINICAL ONCOLOGY
    74. Martenson, ED; Hansson, LO; Nilsson, B; von Schoultz, E; Brahme, EM; Ringborg, U; Hansson, J
      Serum S-100B protein as a prognostic marker in malignant cutaneous melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    75. Ugurel, S; Rappl, G; Tilgen, W; Reinhold, U
      Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival

      JOURNAL OF CLINICAL ONCOLOGY
    76. Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF
      Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    77. Jaffee, EM; Hruban, RH; Biedrzycki, B; Laheru, D; Schepers, K; Sauter, PR; Goemann, M; Coleman, J; Grochow, L; Donehower, RC; Lillemoe, KD; O'Reilly, S; Abrams, RA; Pardoll, DM; Cameron, JL; Yeo, CJ
      Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immuneactivation

      JOURNAL OF CLINICAL ONCOLOGY
    78. Papillon, E; Fournet, J; Zarski, JP
      Antitumoral immunotherapy and gastrointestinal tract: specific immunotherapy using dendritic cells and potential interest of heat shock proteins

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    79. Ribuffo, D; Cavalieri, L; De Vita, F; Massa, R; Prosperi, D; Tuccimei, M; Scuderi, N
      Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    80. Saha, S; Mondal, S
      Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    81. Schadendorf, D
      Tumor-specific therapy strategies in oncology

      ONKOLOGIE
    82. Zheleva, AM; Gadjeva, VG
      Spin labelled nitrosoureas and triazenes and their non-labelled clinicallyused analogues - a comparative study on their physicochemical properties and antimelanomic effects

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    83. So, T; Takenoyama, M; Sugaya, M; Yasuda, M; Eifuku, R; Yoshimatsu, T; Hanagiri, T; Oyama, T; Kodate, M; Osaki, T; Yasumoto, K
      Generation of autologous tumor-specific T cell clones from a patient with adenosquamous carcinoma of the lung

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    84. Wickremesekera, JK; Chen, WX; Cannan, RJ; Stubbs, RS
      Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)yttriummicrospheres

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    85. Li, J; Holmes, LM; Franek, KJ; Burgin, KE; Wagner, TE; Wei, Y
      Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    86. Bear, HD; Roberts, J; Cornell, D; Tombes, MB; Kyle, B
      Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    87. Mazzocchi, A; Melani, C; Rivoltini, L; Castelli, C; Del Vecchio, M; Lombardo, C; Colombo, MP; Parmiani, G
      Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    88. Kobayashi, H; Tanaka, Y; Yagi, J; Toma, H; Uchiyama, T
      Gamma/delta T cells provide innate immunity against renal cell carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    89. Pandolfino, MC; Labarriere, N; Tessier, MH; Cassidanius, A; Bercegeay, S; Lemarre, P; Dehaut, F; Dreno, B; Jotereau, F
      High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    90. Salopek, TG; Scott, JR; Joshua, AV; Smylie, M; Logus, JW; Morin, CA; McEwan, AJB
      Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    91. Braun-Falco, M; Hallek, M
      Recombinant adeno-associated virus (rAAV) vector-mediated cotransduction of CD70 and CD80 into human malignant melanoma cells results in an additive T-cell response

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    92. Parish, CR; Freeman, C; Hulett, MD
      Heparanase: a key enzyme involved in cell invasion

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    93. Schroeder, RJ; Hauff, P; Bartels, T; Vogel, K; Jeschke, J; Hidajat, N; Maeurer, J
      Tumor vascularization in experimental melanomas: Correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading

      ULTRASOUND IN MEDICINE AND BIOLOGY
    94. Koenig, A; Wojcieszyn, J; Weeks, BR; Modiano, JF
      Expression of S100a, vimentin, NSE, and Melan A/MART-1 in seven canine melanoma cell lines and twenty-nine retrospective cases of canine melanoma

      VETERINARY PATHOLOGY
    95. Escott, EJ
      A variety of appearances of malignant melanoma in the head: A review

      RADIOGRAPHICS
    96. Mendoza, L; Carrascal, T; De Luca, M; Fuentes, AM; Salado, C; Blanco, J; Vidal-Vanaclocha, F
      Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: Implications for circulating cancer cell arrest in the murine liver

      HEPATOLOGY
    97. Falk, MH; Issels, RD
      Hyperthermia in oncology

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    98. Hanna, MG; Hoover, HC; Vermorken, JB; Harris, JE; Pinedo, HM
      Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise

      VACCINE
    99. Moingeon, P
      Cancer vaccines

      VACCINE
    100. Nieboer, P; Mulder, NH; Van Der Graaf, WTA; Willemse, PHB; Hospers, GAP
      Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma

      ANTICANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 08:48:57